Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on glycemic response and tolerability
The same compound is found in Mounjaro, also manufactured by Eli Lilly and Company
You dont have to get the highest dose of tirzepatide to see significant results
Cagrilintide is supplied in lyophilized powder form for reconstitution and is designated for research and laboratory use only
Placing recognizable media logos without evidence is a trust tactic, not a trust signal
